Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

The document concludes that understanding how hair follicles naturally die and regenerate is important for insights into organ development and could impact health and disease treatment.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Women of reproductive age with polycystic ovary syndrome often experience hair loss.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Topical tacrolimus reduces certain growth factors in hair follicles.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Nanostructured lipid carriers can improve alopecia treatment by enhancing drug delivery and promoting hair growth.

Common hair loss disorders may not need stem cell therapy, but could benefit from other treatments like hair cycle control and immune restoration therapy.

Keratinocyte growth factor promotes hair growth and reduces hair loss from chemotherapy.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Trichoscopy is easier and quicker than folliscopy for diagnosing telogen effluvium.

Estrogen helps promote hair growth in women with androgenetic alopecia.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

OCT4 helps granulosa cell growth in early-stage follicles, and FSH increases OCT4 through specific pathways.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Two growth factors, PDGF and FGF2, can potentially be used together to grow enough cells for a hair loss treatment, but their exact function on human cells needs further confirmation.

New treatments for hair loss show promise, especially with antiandrogens, minoxidil, and autoimmune therapies.

Tiny glowing gold particles can stop hair growth by blocking a specific cell signal.

Applying certain inhibitors to the skin can promote hair growth without harming cells.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.